High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort Study

BACKGROUND: Extensively drug-resistant Acinetobacter baumannii (XDR-AB) infections have become difficult to treat and are associated with a high mortality rate. Tigecycline is one of the most effective agents used to treat XDR-AB infections, but data from treating bloodstream infection (BSI) in stan...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Hui, Qin, Weidong, Zheng, Yue, Cao, Dongming, Lu, Haining, Zhang, Lu, Cui, Yi, Hu, Yuanyuan, Li, Wei, Guo, Haipeng, Wu, Dawei, Li, Chen, Wang, Hao, Chen, Yuguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457649/
https://www.ncbi.nlm.nih.gov/pubmed/34566417
http://dx.doi.org/10.2147/IDR.S322803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457649/
https://www.ncbi.nlm.nih.gov/pubmed/34566417
http://dx.doi.org/10.2147/IDR.S322803

Ejemplares similares